menu
    • menu

    Company profile for Belharra Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Belharra Therapeutics, Inc. is a privately held drug discovery company whose novel photoaffinity-based chemoproteomics platform is disrupting the drug discovery paradigm. Guided by a diverse team of biotech trailblazers, Belharra’s proprietary noncovalent drug discovery engine is uniquely capable of identifying novel starting points for transformative medicines to address previously impossible-to-treat ...
    Belharra Therapeutics, Inc. is a privately held drug discovery company whose novel photoaffinity-based chemoproteomics platform is disrupting the drug discovery paradigm. Guided by a diverse team of biotech trailblazers, Belharra’s proprietary noncovalent drug discovery engine is uniquely capable of identifying novel starting points for transformative medicines to address previously impossible-to-treat diseases and conditions. 

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Belharra TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3985 Sorrento Valley Boulevard, Suite C San Diego, CA 92121
    Telephone
    Telephone
    (858) 800-4340
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://belharratx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/belharra-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Belharra Names Sean CSO, Announces Gary O’Neill’s Retirement
    Belharra Names Sean CSO, Announces Gary O’Neill’s Retirement

    10 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/10/3007558/0/en/Belharra-Therapeutics-Announces-Appointment-of-Sean-Buchanan-Ph-D-as-Chief-Scientific-Officer-and-Retirement-of-Gary-O-Neill-Ph-D.html

    GLOBENEWSWIRE
    10 Jan 2025
    Share Share
    40% layoffs break Belharra's tidal wave
    40% layoffs break Belharra's tidal wave

    09 Dec 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/belharras-tide-falls-chemoproteomics-biotech-lays-21-workers

    FIERCE BIOTECH
    09 Dec 2024
    Share Share
    Sanofi Partners Belharra AstraZeneca's Cancer Drug Disappoints
    Sanofi Partners Belharra AstraZeneca's Cancer Drug Disappoints

    18 Jun 2024

    // Annalee Armstrong FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/sanofi-heads-out-surf-belharra-700m-biobucks-immunology-deal

    Annalee Armstrong FIERCE BIOTECH
    18 Jun 2024
    Share Share
    Belharra Therapeutics Announces Broad Collaboration with Genentech
    Belharra Therapeutics Announces Broad Collaboration with Genentech

    04 Jan 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230104005763/en

    BUSINESSWIRE
    04 Jan 2023
    Share Share
    Belharra Therapeutics Debuts With $130 Million in Funding
    Belharra Therapeutics Debuts With $130 Million in Funding

    04 Jan 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230104005275/en

    BUSINESSWIRE
    04 Jan 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search